159 related articles for article (PubMed ID: 21079194)
1. The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?
Cozzolino M; Mazzaferro S; Brandenburg V
Nephrol Dial Transplant; 2011 Feb; 26(2):402-7. PubMed ID: 21079194
[No Abstract] [Full Text] [Related]
2. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
[TBL] [Abstract][Full Text] [Related]
3. [Phosphate binders in chronic kidney disease: the positions of sevelamer].
Fomin VV; Shilov EM; Svistunov AA; Milovanov IuS
Ter Arkh; 2013; 85(6):96-9. PubMed ID: 23875200
[TBL] [Abstract][Full Text] [Related]
4. [Phosphate binders : What are the recent evidences ?].
Bouajila IA; Martin PY; De Seigneux S
Rev Med Suisse; 2017 Feb; 13(551):468-472. PubMed ID: 28714648
[TBL] [Abstract][Full Text] [Related]
5. Use of phosphate binders in chronic kidney disease.
Ketteler M; Biggar PH
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
[TBL] [Abstract][Full Text] [Related]
6. [Should we consider the cost-effectiveness analysis to apply the recommendations for phosphate-binders administration?].
Martín de Francisco AL
Nefrologia; 2008; 28(2):129-34. PubMed ID: 18454700
[No Abstract] [Full Text] [Related]
7. Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
Negri AL
J Nephrol; 2010; 23(6):653-7. PubMed ID: 20349415
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi M; Fukagawa M
Clin Calcium; 2010 Nov; 20(11):1700-8. PubMed ID: 21037391
[TBL] [Abstract][Full Text] [Related]
9. Ten-year experience with sevelamer and calcium salts as phosphate binders.
Raggi P; Vukicevic S; Moysés RM; Wesseling K; Spiegel DM
Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S31-40. PubMed ID: 20089501
[TBL] [Abstract][Full Text] [Related]
10. Phosphate binders in moderate chronic kidney disease: where do we stand?
Bellasi A; Cozzolino M; Adragao T; Di Iorio B; Russo D
J Nephrol; 2013; 26(6):993-1000. PubMed ID: 23543481
[TBL] [Abstract][Full Text] [Related]
11. Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III - V).
Biggar P; Ketteler M
Expert Opin Pharmacother; 2010 Nov; 11(16):2739-50. PubMed ID: 20977406
[TBL] [Abstract][Full Text] [Related]
12. [The use of sevelamer in the treatment of resistant hyperphosphataemia in children with chronic renal disease].
Runowski D; Jachimiak B; Cieślak-Puchalska A; Pacanowska B; Zimoń T
Pol Merkur Lekarski; 2009 Apr; 26(154):318-21. PubMed ID: 19580197
[TBL] [Abstract][Full Text] [Related]
13. [Iron-based Phosphate Binders for ESRD Patients].
Cozzolino M; Mangano M; Magagnoli L; Di Lullo L; Galassi A; Brancaccio D; Bellasi A
G Ital Nefrol; 2016; 33(4):. PubMed ID: 27545638
[TBL] [Abstract][Full Text] [Related]
14. [Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].
Malberti F
G Ital Nefrol; 2010; 27 Suppl 52():S47-54. PubMed ID: 21132662
[TBL] [Abstract][Full Text] [Related]
15. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
West SL; Swan VJ; Jamal SA
Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
[TBL] [Abstract][Full Text] [Related]
16. Phosphate management in chronic kidney disease.
Bhan I
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):174-9. PubMed ID: 24445424
[TBL] [Abstract][Full Text] [Related]
17. [Management of hyperphosphatemia ; phosphate-binder].
Yokoyama K
Clin Calcium; 2009 Feb; 19(2):205-12. PubMed ID: 19182360
[TBL] [Abstract][Full Text] [Related]
18. Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of life.
Gardulf A; Pålsson M; Nicolay U;
Clin Nephrol; 2011 Apr; 75(4):319-27. PubMed ID: 21426886
[TBL] [Abstract][Full Text] [Related]
19. Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.
Galassi A; Cupisti A; Santoro A; Cozzolino M
J Nephrol; 2015 Aug; 28(4):415-29. PubMed ID: 25245472
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for hyperphosphatemia in feline CKD: what's out there?
Kidder AC; Chew D
J Feline Med Surg; 2009 Nov; 11(11):913-24. PubMed ID: 19857854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]